Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis-Reference-Cited by-同舟云学术

Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis

Published:2005 Issue:4 Volume:14 Page:327-338
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Econ.

Author:

Willan Andrew R.,Pinto Eleanor M.,O'Brien Bernie J.,Kaul Padma,Goeree Ron,Lynd Larry,Armstrong Paul W.

Publisher

Wiley

Subject

Health Policy

Reference26 articles.

1. Economic Analysis in Randomized Control Trials

2. Methods for Economic Evaluation of Health Care Programmes (2nd edn). Oxford University Press: Oxford, 1997.

3. Economic Evaluation Alongside Multinational Clinical Trials: Study Considerations for GUSTO iib

4. Estimating country-specific cost-effectiveness from multinational clinical trials

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data;Medical Decision Making;2021-04-05

2. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial;Trials;2019-12

3. The Impact of Treatments for OSA on Monetized Health Economic Outcomes;Chest;2019-05

4. Analyse économique des essais cliniques internationaux en cancérologie;Bulletin du Cancer;2018-02

5. Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size;Medical Decision Making;2017-08-19